French Translation and Validation of the PEYronie's Disease QUESTionnaire

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05768867

Acronym

FRAPEYQUEST

Enrollment

Registered

2023-03-14

Start date

2023-03-06

Completion date

2023-05-22

Last updated

2024-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peyronie Disease

Brief summary

This study is a prospective cohort dedicated to peyronie's disease. The aim is to validate the french translation of the peyronie's disease questionnaire. The primary endpoint is the response rate to the questionnaire.

Interventions

OTHERFRAnçaise du PEYronie's Disease QUESTionnaire

Complete an online FRAnçaise du PEYronie's Disease QUESTionnaire

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patient with Peyronie's Disease clinically diagnosed during a consultation, with palpation of at least one plaque

Exclusion criteria

* Patient refusing to participate * Patient with difficulties in understanding the French language. * Protected persons referred to in articles L.1121-6 to L.1121-8 of the public health code

Design outcomes

Primary

Measure	Time frame	Description
Rate of responses	Day 0	Response rate to the online questionnaire.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026